Cybersecurity and the Artificial Pancreas

“Cybersecurity and the Artificial Pancreas ” appears to be the subject of this week’s Press Release of the Week. The press release, issued by the Mary-Ann-Liebert-centric entity that calls itself “Mary Ann Liebert, Inc., Publishers”, has been reprinted in several places as a news article. It begins:

Cybersecurity and the Artificial Pancreas—What are the Risks?

liebertNew Rochelle, NY, May 12, 2015—An artificial pancreas, designed for blood glucose control in diabetes, is controlled by software that runs on mobile computing platforms such as laptops, tablets, and smartphones, and operates over wireless networks under local or remote medical supervision. As optimal function is critical to an individual’s health, safety, and privacy, the risk of security threats targeting an artificial pancreas is of paramount concern and has not been sufficiently considered in the research and development of these emerging medical devices, according to a Perspective article published in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers….

The press release touts this study:

Cybersecurity in Artificial Pancreas Experiments,” Derek T. O’Keeffe, MB, BCh, BAO, BEng, MEng, PhD, Spyridoula Maraka, MD, Ananda Basu, MD, Patrick Keith-Hynes, PhD, and Yogish C. Kudva, MD., Diabetes Technology and Therapeutics, Volume 17, Number 8, 2015. The authors are at the Mayo Clinic, Rochester, Minnesota, and at the University of Virginia, Charlottesville, Virginia.

(Thanks to Ivan Oransky for bringing this to our attention.)

BONUS: More about Mary Ann Liebert [pictured above]